140 results
8-K
EX-99.1
SMTI
Sanara MedTech Inc
18 Apr 24
Sanara MedTech Inc. Announces $55 Million Debt Facility
9:20am
to the safe harbor created by the Private Securities Litigation Reform Act of 1995. These statements may be identified by terms such as “aims,” “anticipates
8-K
EX-10.1
SMTI
Sanara MedTech Inc
18 Apr 24
Sanara MedTech Inc. Announces $55 Million Debt Facility
9:20am
Commitments
Schedule 7.05(b)(i)
Intellectual Property
Schedule 7.05(b)(ii)
Intellectual Property Exceptions
Schedule 7.06
Certain Litigation
Schedule … .
(a) Litigation. There is no litigation, investigation or proceeding pending, or, to any Obligor’s Knowledge, threatened in writing, with respect
8-K
EX-10.2
SMTI
Sanara MedTech Inc
18 Apr 24
Sanara MedTech Inc. Announces $55 Million Debt Facility
9:20am
OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE
8-K
EX-10.1
SMTI
Sanara MedTech Inc
5 Apr 24
Departure of Directors or Certain Officers
9:15am
costs and expenses and an equal share of the arbitrator’s and administrative fees of arbitration.
17. Attorneys’ Fees. If any litigation is instituted
8-K
EX-99.1
SMTI
Sanara MedTech Inc
5 Apr 24
Departure of Directors or Certain Officers
9:15am
are “forward-looking statements,” within the meaning of and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995
8-K
EX-99.1
exk5fhv2lusqpur5m2xo
25 Mar 24
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results
4:37pm
8-K
EX-99.1
warljmd4c
22 Feb 24
Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023
4:01pm
8-K
EX-99.1
bti8prwzh7pn
13 Nov 23
Sanara MedTech Inc. Announces Third Quarter 2023 Results
4:42pm
8-K
EX-99.1
zka9xgsvf831bz6vc9gj
14 Aug 23
Sanara MedTech Inc. Announces Second Quarter 2023 Results
5:11pm
8-K
EX-99.1
ie9beg7mfg7m iy47q9
2 Aug 23
Sanara MedTech Inc. Announces the Acquisition of Certain Assets Related to its Collagen Products Business
9:20am
8-K
EX-2.1
1e0nmgsi4 90zc7nlki
2 Aug 23
Sanara MedTech Inc. Announces the Acquisition of Certain Assets Related to its Collagen Products Business
9:20am
8-K
EX-10.2
j13q9z2ynsmofi
2 Aug 23
Sanara MedTech Inc. Announces the Acquisition of Certain Assets Related to its Collagen Products Business
9:20am
8-K
EX-10.1
quk6im a8s
2 Aug 23
Sanara MedTech Inc. Announces the Acquisition of Certain Assets Related to its Collagen Products Business
9:20am
8-K
EX-99.1
m64qdlj kngvx4
15 May 23
Sanara MedTech Inc. Announces First Quarter 2023 Results
4:19pm
8-K
EX-99.1
bkavrgp6s
14 Nov 22
Sanara MedTech Inc. Announces Third Quarter 2022 Results
4:40pm
8-K
EX-99.1
f5sb 02p05n
15 Aug 22
Sanara MedTech Inc. Announces Second Quarter 2022 Results
6:10pm
8-K
EX-99.1
i987f6o qe
5 Jul 22
Sanara MedTech Inc. Announces Closing of Scendia Biologics, LLC Acquisition
9:20am
8-K
EX-2.1
mah4p90k3lo0m6yiho
5 Jul 22
Sanara MedTech Inc. Announces Closing of Scendia Biologics, LLC Acquisition
9:20am
8-K
EX-99.1
c8t6e7l8u41 iq
16 May 22
Sanara MedTech Inc. Announces First Quarter 2022 Results
4:36pm